Exacerbated α-synuclein pathology (22, 23), accelerated breakdown of the BBB (24), and faster cognitive decline (22) reported in PD patients with APOE ε4 allele may be early evidence of accelerated neurodegeneration seen in our PD patients. This evidence concerns the gene APOE and Parkinson disease.